Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02356250

A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic Patients

A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Eyal Ashkenazi · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Rationale for the study: To try and define PEF in cirrhotic patients with CSPH, and maybe to try to find a correlation between HVPG ( hepatic vein pressure gradient ) result and PEF result in a way that the result of the PEF test will be able to predict if a patient has CSPH (yes of no). By this, to try and develop a portable office-based device that can produce immediate results in a non-invasive manner in cirrhotic patients and help in evaluating prognosis in these patients in a noninvasive manner. Aim: The aim of this study is to try and characterize the peripheral endothelial function (PEF) in patient with cirrhosis and CSPH. This will be evaluated by measuring the PEF in every patient before evaluating his HVPG level in a hemodynamic study.

Detailed description

To try and define PEF in cirrhotic patients with CSPH, and maybe to try to find a correlation between HVPG result and PEF result in a way that the result of the PEF test will be able to predict if a patient has CSPH (yes of no). By this, to try and develop a portable office-based device that can produce immediate results in a non-invasive manner in cirrhotic patients and help in evaluating prognosis in these patients in a noninvasive manner

Conditions

Timeline

Start date
2015-02-18
Primary completion
2016-11-29
Completion
2016-11-29
First posted
2015-02-05
Last updated
2018-07-26

Source: ClinicalTrials.gov record NCT02356250. Inclusion in this directory is not an endorsement.